Comparison transdermal oral estradiol administration hormonal hepatic parameters women premature ovarian failure women premature ovarian failure randomized cross-over design biochemical effects transdermal oral estradiol administration doses endometrial preparation donor oocyte program Patients dosages oral transdermal estradiol week progesterone last weeks normal hormonal cycle Serum samples treatment premenopausal controls general serum estradiol normal range treatment groups whereas serum estrone levels group group Serum levels sex hormone-binding globulin thyroid binding globulin substrate day treated patients unchanged transdermal subjects plasminogen route administration antithrombin-III levels treatments Changes gonadotropin levels similar groups suppression FSH end simulated cycles normal premenopausal range conclusion replacement regimens near-normal serum estradiol profiles high doses necessary normal cycle transdermal route hepatic parameters route administration adverse hepatic effects 